GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Laboratories Ltd (BOM:538964) » Definitions » Cyclically Adjusted PS Ratio

Mercury Laboratories (BOM:538964) Cyclically Adjusted PS Ratio : 1.31 (As of Jun. 04, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Mercury Laboratories Cyclically Adjusted PS Ratio?

As of today (2025-06-04), Mercury Laboratories's current share price is ₹821.35. Mercury Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₹629.04. Mercury Laboratories's Cyclically Adjusted PS Ratio for today is 1.31.

The historical rank and industry rank for Mercury Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:538964' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.3   Med: 1.48   Max: 2.05
Current: 1.3

During the past years, Mercury Laboratories's highest Cyclically Adjusted PS Ratio was 2.05. The lowest was 1.30. And the median was 1.48.

BOM:538964's Cyclically Adjusted PS Ratio is ranked better than
67.07% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs BOM:538964: 1.30

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Mercury Laboratories's adjusted revenue per share data for the three months ended in Mar. 2025 was ₹172.159. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹629.04 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mercury Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Mercury Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Laboratories Cyclically Adjusted PS Ratio Chart

Mercury Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.38 1.30

Mercury Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.54 1.59 1.43 1.30

Competitive Comparison of Mercury Laboratories's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercury Laboratories's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Mercury Laboratories's Cyclically Adjusted PS Ratio falls into.


;
;

Mercury Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Mercury Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=821.35/629.04
=1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercury Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Mercury Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=172.159/157.5517*157.5517
=172.159

Current CPI (Mar. 2025) = 157.5517.

Mercury Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 107.502 99.841 169.642
201509 102.045 101.753 158.003
201512 104.773 102.901 160.418
201603 81.659 102.518 125.495
201606 107.504 105.961 159.846
201609 96.714 105.961 143.802
201612 87.850 105.196 131.573
201703 108.435 105.196 162.403
201706 88.755 107.109 130.554
201709 121.063 109.021 174.954
201712 115.420 109.404 166.215
201803 107.172 109.786 153.800
201806 108.623 111.317 153.739
201809 107.437 115.142 147.009
201812 146.080 115.142 199.885
201903 100.625 118.202 134.123
201906 122.930 120.880 160.224
201909 126.433 123.175 161.719
201912 129.777 126.235 161.972
202003 98.104 124.705 123.944
202006 111.376 127.000 138.169
202009 157.586 130.118 190.811
202012 154.624 130.889 186.121
202103 148.186 131.771 177.179
202106 129.360 134.084 152.001
202109 112.180 135.847 130.103
202112 130.038 138.161 148.289
202203 111.199 138.822 126.202
202206 146.658 142.347 162.323
202209 183.937 144.661 200.327
202212 135.146 145.763 146.076
202303 161.928 146.865 173.711
202306 152.683 150.280 160.071
202309 189.626 151.492 197.211
202312 142.623 152.924 146.939
202403 144.727 153.035 148.999
202406 139.204 155.789 140.779
202409 151.617 157.882 151.300
202412 163.096 158.323 162.302
202503 172.159 157.552 172.159

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mercury Laboratories  (BOM:538964) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Mercury Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Mercury Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mercury Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016
Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and internationally, of which key revenue is derived from sales made in India.

Mercury Laboratories Headlines

No Headlines